Regulation of adipocytokines and insulin resistance M. FasshauerR. Paschke Review 06 November 2003 Pages: 1594 - 1603
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI T. den HeijerS. E. VermeerM. M. B. Breteler Article 01 November 2003 Pages: 1604 - 1610
Change in patients’ body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrolective cohort study S. MartinH. KolbW. A. Scherbaum Article 05 November 2003 Pages: 1611 - 1617
Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes R. HernandezT. TeruelM. Lorenzo Article 01 November 2003 Pages: 1618 - 1628
Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats J. B. C. CarvalheiraE. B. RibeiroM. J. A. Saad Article 05 November 2003 Pages: 1629 - 1640
Global profiling of double stranded RNA- and IFN-γ-induced genes in rat pancreatic beta cells J. RasschaertD. LiuD. L. Eizirik Article 05 November 2003 Pages: 1641 - 1657
Effects of recurrent antecedent hypoglycaemia and chronic hyperglycaemia on brainstem extra-cellular glucose concentrations during acute hypoglycaemia in conscious diabetic BB rats R. J. McCrimmonR. J. JacobR. S. Sherwin Short Communication 05 November 2003 Pages: 1658 - 1661
Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance T. FerreE. RiuF. Bosch Article 12 November 2003 Pages: 1662 - 1668
Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats A. A. BoscoA. C. LerarioB. L. Wajchenberg Article 04 November 2003 Pages: 1669 - 1675
Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells C. B. RenardB. AskariK. E. Bornfeldt Article 01 November 2003 Pages: 1676 - 1687
Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats J. ZhaoJ. YangH. Gregersen Article 31 October 2003 Pages: 1688 - 1697
Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats T. KitamuraK. KimuraM. Saito Article 30 October 2003 Pages: 1698 - 1705
To: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426–428 D. P. K. NgJ. H. WarramA. S. Krolewski Comment 01 November 2003 Pages: 1706 - 1706
—to: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426–428 M. J. ZychmaJ. GumprechtW. Grzeszczak Comment 12 November 2003 Pages: 1707 - 1708
–To: Poa NR, Cooper GJS, Edgar PF: Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori. Diabetologia 46: 574–578 A. NovialsA. KistauriR. Gomis Comment 05 November 2003 Pages: 1708 - 1709
Absence of association between SPINK1 trypsin inhibitor mutations and Type 1 or 2 diabetes mellitus in India and Germany E. BhatiaO. KordonouriH. Witt Observation 01 November 2003 Pages: 1710 - 1711
The diabetes prone BB rat model of IDDM shows duration of breastfeeding to influence Type 1 diabetes development later in life J. VisserH. GroenJ. Rozing Observation 01 November 2003 Pages: 1711 - 1713
Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan M. ElsnerM. TiedgeS. Lenzen Observation 12 November 2003 Pages: 1713 - 1714
